Published on
February 13, 2024
- 13:05 GMT
Wandercraft's self-balancing exoskeleton receives second FDA clearance in less than a year, now indicated for rehabilitation in ...
Wandercraft's self-balancing exoskeleton receives second FDA clearance in less than a year, now indicated for rehabilitation in patients with spinal cord injury This marks Wandercraft’s second FDA clearance for Atalante X, the world’s first self- …
Distribution channels:
Healthcare & Pharmaceuticals Industry
...
